| A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients |
Completed |
Travoprost 0.004% / Timolol |
3 |
C-12-008 |
King Khaled Eye Specialist Hospital (Riyadh) |
| A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center Study to Compare the Efficacy, Safety and Tolerability of ITCA 650 to Sitagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes |
Completed |
ITCA 650 |
3 |
ITCA 650-CLP-105 |
King Abdulaziz Medical City NG (Jeddah)_ King Abdulaziz Hospital NG (Al Ahsa)_ Imam Abdulrahman Al Faisal Hospital NG (Dammam)_ King Fahad Medical City (Riyadh) |
| Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled |
Completed |
Lantus® / Glimepiride / human insulin [NPH] |
3 |
LANTU_C_02762 |
King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah) |
| "Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection" |
Completed |
TMC435 (simeprevir) / Pegylated interferon alfa-2a (PegIFNα-2a) / Ribavirin (RBV) |
3b |
TMC435HPC3014 |
King Faisal Specialist Hospital and Research Center (Riyadh)_ King Abdulaziz Medical City NG (Riyadh)_ King Khalid University Hospital (Riyadh) |
| Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation With a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients |
Completed |
Innohep (Tinzaparin) / Warfarin |
3 |
IN 0901 INT |
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam), King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh) |
| An Open-Label, Multicenter, Multinational Study of the Safety, Efficacy and Pharmacokinetics of Asfotase Alfa (human recombinant tissue non-specific alkaline phosphatase fusion protein) in Infants and Children ≤ 5 Years of Age with Hypophosphatasia (HPP). |
Completed |
Asfotase Alfa |
2 |
ENB-010-10 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy |
Completed |
Irbesartan Amlodipine |
3 |
IRBAM_R_04219 |
King Abdulaziz Medical City NG (Jeddah) |
| Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age) |
Completed |
Meningococcal ACWY Conjugate Vaccine |
3b |
107402 |
King Abdulaziz Medical City NG (Riyadh) |
| Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF |
Completed |
Tocilizumab |
3 |
ML22726 |
King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh), King Abdulaziz University Hospital (Jeddah), Hira Hospital (Makkah) |
| An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment |
Completed |
BIBW 2992 / Vinorelbine / Trastuzumab |
3 |
1200.75 |
King Fahad Medical City (Riyadh), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
